Skip to content
Back to announcement

20260206_OMED_Laporan Informasi dan Fakta Material_32025484_lamp4.pdf

Other Text extracted OMED

Source file signed link, expires in 15 minutes

This browser can't display the PDF inline. Open it in a new tab.

Extracted text 1

Page 1
                                                                                                                                 Contact Us
                                                                                                                                 ir@onemed.co.id
                                                                                                                                 corporate.secretary@onemed.co.id


 OMED INVESTOR NEWSLETTER - MESSAGE FROM MANAGEMENT
 FEBRUARY 5, 2026

 Indonesia Healthcare Sector Update: Structural Support, Private-Led
 Resilience
  Government Spending Budget for Healthcare                                                     Indonesia’s healthcare sector continues to benefit from strong
 350 (Rptn)              Indonesia healthcare budget              % growth, YoY          100%   structural support from the government, even as market
 300                                                                                     80%    participants remain attentive to funding dynamics within the
 250
                                                                                         60%    universal healthcare system (BPJS). For 2026, the Government of
                                                                                         40%    Indonesia has increased its healthcare budget by 16% year-on-
                                                                                                year to approximately Rp244 trillion, reaffirming healthcare as a
 200
                                                                                         20%
 150
                                                                                         0%     national priority. Policy objectives remain focused on improving
 100
                                                                                         -20%   accessibility, affordability, and long-term sustainability, including
  50                                                                                     -40%
                                                                                                strengthening domestic healthcare and pharmaceutical
      0                                                                                  -60%
                                                                                                capabilities.
          2019     2020        2021       2022    2023     2024       2025     2026

 Source: Ministry of Finance                                                                    While BPJS remains critical in expanding healthcare access,
                                                                                                funding pressures persist as claim ratios exceed premium
                   Healthcare Budget Allocation
                                                                                                income, prompting the expected rollout of measures such as the
                                                                                                Standardized Inpatient Class (KRIS) and a competency-based
 80 (Rptn)                       Budget                  % of total                      30%
 70
 60
                                                                                         25%
                                                                                                referral system from the second half of 2026 to improve
 50
                                                                                         20%    efficiency and sustainability. In this context, sector research
 40                                                                                      15%    indicates that the private healthcare segment remains more
 30
                                                                                         10%    resilient, supported by steady demand for higher-complexity and
 20
 10
                                                                                         5%     non-BPJS services as well as continued demand for medical
  0                                                                                      0%
                                                                                                devices, consumables, and healthcare infrastructure, leading us
          BPJS subsidy       General Allocation Nutritious food for Operational health
                              Fund (DAU) for       pregnant /             funds
                                                                                                to view the healthcare sector outlook for 2026 as constructive,
                                  health          breastfeeding
                                                mothers & toddlers
                                                                                                underpinned by resilient private sector activity and
Source: Ministry of Finance, Ministry of Health                                                 increased government healthcare spending.

 OMED Management’s View for 2026: Solid Fundamentals, Disciplined
 Expansion
  Management of PT Jayamas Medica Industri Tbk (OMED) remains confident in the Company’s operating outlook
  for 2026, supported by stable demand across both private and public healthcare segments.
  Key elements of management’s 2026 outlook include:
  1. Low-to-mid teens revenue growth (up to ~15%)
  2. Gross margins sustained in the low-30% range
  3. Export sales target of USD 1.0–1.5 million
  4. Continued strength from the private sector, alongside a supportive government healthcare spending
        environment
  To support long-term growth and operational readiness, OMED plans capital expenditure of approximately Rp62
  billion in 2026, primarily allocated to:
  1. Acquisition of new machinery to expand manufacturing capacity in Mojoagung and Krian facility; and
  2. Development of the National Distribution Center (NDC) in Pulo Gadung, Jakarta, to enhance logistics
        efficiency and service levels especially in Jabodetabek and West Java area.
  While near-term equity market movements may be influenced by broader structural and index-related factors,
  management remains focused on execution, capacity building, and sustainable value creation. OMED
  enters 2026 with a solid balance between growth initiatives and operational discipline, positioning the Company to
  navigate market volatility while maintaining long-term growth momentum.
          https://www.onemed.co.id/                                    https://www.tokopedia.com/onemed               https://shopee.co.id/onemed     https://omed.idx

File

File Open PDF
Source IDX
Size0.15 MB
Published6 Feb 2026
Pages1
Characters6,791
Text sourceEmbedded text layer
OCR confidence—

Names mentioned 3 people and organisations named in the text · linked when the evidence is strong

linked org Jayamas Medica Industri Tbk p.1 ×2
unresolved org Ministry of Finance p.1 ×2
unresolved org Ministry of Health p.1

Extraction attempts how the parser did, and what it refused

Nothing structured was extracted from this document — the attempts below say why.

No extraction attempted yet.

↑↓ select ↵ open ⇧↵ see every result